These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 14993244)

  • 61. Inducible expression of phospholipid transfer protein (PLTP) in transgenic mice: acute effects of PLTP on lipoprotein metabolism.
    Moerland M; Anghelescu N; Samyn H; van Haperen R; van Gent T; Strouboulis J; van Tol A; Grosveld F; de Crom R
    Transgenic Res; 2007 Aug; 16(4):503-13. PubMed ID: 17437182
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lowering of plasma phospholipid transfer protein activity by acute hyperglycaemia-induced hyperinsulinaemia in healthy men.
    Van Tol A; Ligtenberg JJ; Riemens SC; van Haeften TW; Reitsma WD; Dullaart RP
    Scand J Clin Lab Invest; 1997 Apr; 57(2):147-57. PubMed ID: 9200274
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Liver-specific phospholipid transfer protein deficiency reduces high-density lipoprotein and non-high-density lipoprotein production in mice.
    Yazdanyar A; Quan W; Jin W; Jiang XC
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2058-64. PubMed ID: 23846500
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The impact of phospholipid transfer protein (PLTP) on HDL metabolism.
    Huuskonen J; Olkkonen VM; Jauhiainen M; Ehnholm C
    Atherosclerosis; 2001 Apr; 155(2):269-81. PubMed ID: 11254896
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
    Valenta DT; Ogier N; Bradshaw G; Black AS; Bonnet DJ; Lagrost L; Curtiss LK; Desrumaux CM
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1572-8. PubMed ID: 16675720
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels.
    Hayek T; Chajek-Shaul T; Walsh A; Agellon LB; Moulin P; Tall AR; Breslow JL
    J Clin Invest; 1992 Aug; 90(2):505-10. PubMed ID: 1644921
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Macrophage PLTP is atheroprotective in LDLr-deficient mice with systemic PLTP deficiency.
    Valenta DT; Bulgrien JJ; Bonnet DJ; Curtiss LK
    J Lipid Res; 2008 Jan; 49(1):24-32. PubMed ID: 17928634
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Structural basis of the lipid transfer mechanism of phospholipid transfer protein (PLTP).
    Zhang M; Zhai X; Li J; Albers JJ; Vuletic S; Ren G
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1082-1094. PubMed ID: 29883800
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Human plasma phospholipid transfer protein causes high density lipoprotein conversion.
    Jauhiainen M; Metso J; Pahlman R; Blomqvist S; van Tol A; Ehnholm C
    J Biol Chem; 1993 Feb; 268(6):4032-6. PubMed ID: 8440695
    [TBL] [Abstract][Full Text] [Related]  

  • 70. PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity.
    Yan D; Navab M; Bruce C; Fogelman AM; Jiang XC
    J Lipid Res; 2004 Oct; 45(10):1852-8. PubMed ID: 15258196
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein.
    Marotti KR; Castle CK; Boyle TP; Lin AH; Murray RW; Melchior GW
    Nature; 1993 Jul; 364(6432):73-5. PubMed ID: 8316302
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Molecular and macromolecular specificity of human plasma phospholipid transfer protein.
    Rao R; Albers JJ; Wolfbauer G; Pownall HJ
    Biochemistry; 1997 Mar; 36(12):3645-53. PubMed ID: 9132017
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Plasma lipid transfer proteins.
    Tall A
    Annu Rev Biochem; 1995; 64():235-57. PubMed ID: 7574481
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cholesteryl ester transfer protein expression attenuates atherosclerosis in ovariectomized mice.
    Cazita PM; Berti JA; Aoki C; Gidlund M; Harada LM; Nunes VS; Quintão EC; Oliveira HC
    J Lipid Res; 2003 Jan; 44(1):33-40. PubMed ID: 12518020
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients.
    Riemens SC; van Tol A; Sluiter WJ; Dullaart RP
    Diabetologia; 1998 Aug; 41(8):929-34. PubMed ID: 9726595
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Increased fecal bile acid excretion in transgenic mice with elevated expression of human phospholipid transfer protein.
    Post SM; de Crom R; van Haperen R; van Tol A; Princen HM
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):892-7. PubMed ID: 12649089
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Human plasma phospholipid transfer protein specific activity is correlated with HDL size: implications for lipoprotein physiology.
    Cheung MC; Wolfbauer G; Deguchi H; Fernández JA; Griffin JH; Albers JJ
    Biochim Biophys Acta; 2009 Mar; 1791(3):206-11. PubMed ID: 19162221
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cholesteryl ester transfer protein: an enigmatic protein.
    Moulin P
    Horm Res; 1996; 45(3-5):238-44. PubMed ID: 8964591
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism.
    Dullaart RP; Sluiter WJ; Dikkeschei LD; Hoogenberg K; Van Tol A
    Eur J Clin Invest; 1994 Mar; 24(3):188-94. PubMed ID: 8033953
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Elevation of systemic PLTP, but not macrophage-PLTP, impairs macrophage reverse cholesterol transport in transgenic mice.
    Samyn H; Moerland M; van Gent T; van Haperen R; Grosveld F; van Tol A; de Crom R
    Atherosclerosis; 2009 Jun; 204(2):429-34. PubMed ID: 19100548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.